Loading page...

Back
RFA-NS-27-007 Open
Send to:
National Institutes of Health United States

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Open Health Posted 16 Jun 2026
Deadline 20 Feb 2029, 00:00 875 days left
Total funding $11,000,000
Expected awards 3

Overview

Funding agency
National Institutes of Health HHS-NIH11
Reference
RFA-NS-27-007
Funding programme
Health
Funding instrument
Cooperative agreement
Cost sharing
Not required
Region
United States
Source
Grants.gov (US Federal)

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to support the preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics for the treatment of pain. The goal of the program is to accelerate the advancement of promising early-stage therapeutic candidates and facilitate their readiness for Phase II clinical trials. Applicants…

Sign up to view full grant details

Create a free account to unlock the complete grant description, funding details, eligibility criteria, and application links.

Full description Funding amounts & eligibility Application links & deadlines Save & track grants

Send to CRM

CRM Integration Required

To send grants directly to your CRM, you need to connect your CRM system to TenderPipe first.

Configure CRM in Settings

Email Grant

Scroll to Top